Kathleen I. Pritchard

Kathleen I. Pritchard

University of Toronto

H-index: 119

North America-Canada

About Kathleen I. Pritchard

Kathleen I. Pritchard, With an exceptional h-index of 119 and a recent h-index of 61 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of Adjuvant Therapy for Breast Cancer, Endocrine Therapy for Breast Cancer, Correlative and Translational Research in Breast Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study

Results of the phase I CCTG IND. 231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Cardiac monitoring and heart failure in advanced breast cancer patients treated with trastuzumab in Ontario, Canada

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta …

The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

Kathleen I. Pritchard Information

University

Position

Professor Division of Medical Oncology

Citations(all)

94876

Citations(since 2020)

29968

Cited By

76387

hIndex(all)

119

hIndex(since 2020)

61

i10Index(all)

386

i10Index(since 2020)

213

Email

University Profile Page

University of Toronto

Google Scholar

View Google Scholar Profile

Kathleen I. Pritchard Skills & Research Interests

Adjuvant Therapy for Breast Cancer

Endocrine Therapy for Breast Cancer

Correlative and Translational Research in Breast Cancer

Top articles of Kathleen I. Pritchard

Title

Journal

Author(s)

Publication Date

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

The Lancet

Carolyn Taylor

David Dodwell

Paul McGale

Robert K Hills

Richard Berry

...

2023/11/25

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study

British journal of cancer

Guilherme Nader-Marta

Véronique Debien

Daniel Eiger

Zoi Tsourti

Rafael Caparica

...

2022/11/9

Results of the phase I CCTG IND. 231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Nature communications

John Hilton

Karen Gelmon

Philippe L Bedard

Dongsheng Tu

Hong Xu

...

2022/6/24

Cardiac monitoring and heart failure in advanced breast cancer patients treated with trastuzumab in Ontario, Canada

Frontiers in Cardiovascular Medicine

Moira Rushton

Coralea Kappel

Isac Lima

Meltem Tuna

Kathleen Pritchard

...

2022/5/19

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta …

The Lancet Oncology

Rosie Bradley

Jeremy Braybrooke

Richard Gray

Robert K Hills

Zulian Liu

...

2022/3/1

The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

The Breast

Phillip S Blanchette

Melody Lam

Britney Le

Lucie Richard

Salimah Z Shariff

...

2021/12/1

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

The Lancet Oncology

Rosie Bradley

Jeremy Braybrooke

Richard Gray

Robert Hills

Zulian Liu

...

2021/8/1

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

European Journal of Cancer

Alvaro Moreno-Aspitia

Eileen M Holmes

Christian Jackisch

Evandro de Azambuja

Frances Boyle

...

2021/5/1

Predictive significance of an optimized panel for basal-like breast cancer: Results from the Canadian cancer trials group MA. 5 and MA. 12 phase iii clinical trials

Clinical Cancer Research

Karama Asleh

Dongsheng Tu

Dongxia Gao

Vivien Bramwell

Mark N Levine

...

2021/12/1

Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

Breast cancer research and treatment

Phillip S Blanchette

Melody Lam

Lucie Richard

Britney Allen

Salimah Z Shariff

...

2020/1

Abstract P3-11-01: An updated systematic review and meta-analysis of the safety and efficacy of phosphoinositide 3-kinase inhibitors (PI3Ki) in advanced breast cancer

Jacques Raphael

Syed Hussaini

Kathleen I Pritchard

Prakesh Shah

Phillip Blanchette

...

2020/2/15

The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer

NPJ Breast Cancer

Pamela J Goodwin

Roanne J Segal

Michael Vallis

Jennifer A Ligibel

Gregory R Pond

...

2020/2/21

Triple-negative breast cancer

Xiyun Deng

Faqing Tang

Thomas J Rosol

2020/10/29

Abstract P4-10-29: Identifying novel molecular markers of response to trastuzumab in metastatic breast cancer

Cancer Research

Katarzyna Joanna Jerzak

Danielle N Desautels

Phillip S Blanchette

Jane Bayani

Sharon Nofech-Mozes

...

2020/2/15

Early modulation of circulating microRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

International journal of molecular sciences

Serena Di Cosimo

Valentina Appierto

Sara Pizzamiglio

Marco Silvestri

José Baselga

...

2020/2/18

221P Long-term outcomes of patients with node-negative,≤ 3cm, HER2+ breast cancer (BC) enrolled in ALTTO

Annals of Oncology

D Eiger

Z Tsourti

R Caparica

M Kassapian

S Napoleone

...

2020/9/1

Abstract P5-08-08: Risk reducing mastectomy in average and high risk patients with locally advanced triple negative breast cancer

Cancer Research

Neda Stjepanovic

Danilo Giffoni

Sonal Gandhi

Katarzyna Jerzak

Sharon Lemon

...

2020/2/15

Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?

Cancer Research

Moira K Rushton-Marovac

Isac Lima

Meltem Tuna

Chiara Melloni

Kathy Pritchard

...

2020/2/15

Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study

NPJ breast cancer

Mitchell J Elliott

Marguerite Ennis

Kathleen I Pritchard

Carol Townsley

Dave Warr

...

2020/6/12

An updated systematic review and meta-analysis of the safety and efficacy of phosphoinositide 3-kinase inhibitors (PI3Ki) in advanced breast cancer

Benedict RH Turner

Matthew Machin

Marwah Salih

Sara Jasionowska

Rebecca Lawton

...

2024/1/1

See List of Professors in Kathleen I. Pritchard University(University of Toronto)